Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronomodulated Chemotherapy in Advanced Nasopharyngeal Cancer
NCT03196869Phase 2Unknown
- Sponsor
- Guizhou Medical University
- Start
- Apr 2017
- Primary completion
- Apr 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lobaplatin in nasopharyngeal carcinoma (NPC), sponsored by Guizhou Medical University. Status: unknown.
02
Drugs
lobaplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03196869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03196869.